Qube Research & Technologies LTD Teva Pharmaceutical Industries LTD Transaction History

Qube Research & Technologies LTD

$62.3 Billion
Q2 2024

A detailed history of Qube Research & Technologies LTD transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Qube Research & Technologies LTD holds 2,083,999 shares of TEVA stock, worth $37.2 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,083,999

Previous 61,780 3273.26%

Holding current value

$37.2 Million

Previous $871,000 3787.94%

% of portfolio

0.05%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$12.78 - $17.4 $25.8 Million - $35.2 Million	2,022,219 Added 3273.26%	2,083,999 $33.9 Million
Q1 2024 May 14, 2024	BUY	$10.67 - $14.43 $659,192 - $891,485	61,780 New	61,780 $871,000
Q2 2023 Aug 14, 2023	BUY	$7.2 - $9.47 $1.63 Million - $2.15 Million	226,841 Added 16.3%	1,618,232 $12.2 Million
Q1 2023 May 15, 2023	BUY	$8.36 - $11.37 $11.6 Million - $15.8 Million	1,391,391 New	1,391,391 $12.3 Million
Q3 2022 Nov 14, 2022	BUY	$6.86 - $11.95 $13.3 Million - $23.1 Million	1,933,334 Added 682.55%	2,216,584 $17.9 Million
Q2 2022 Aug 15, 2022	BUY	$7.38 - $10.4 $2.09 Million - $2.95 Million	283,250 New	283,250 $2.13 Million
Q3 2021 Nov 12, 2021	SELL	$8.38 - $10.18 $2.92 Million - $3.54 Million	-348,175 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$9.9 - $11.56 $3.45 Million - $4.02 Million	348,175 New	348,175 $3.45 Million
Q4 2020 Feb 16, 2021	SELL	$8.61 - $11.04 $518,287 - $664,563	-60,196 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$8.57 - $12.69 $998,293 - $1.48 Million	-116,487 Reduced 65.93%	60,196 $542,000
Q2 2020 Aug 14, 2020	BUY	$8.12 - $13.12 $1.43 Million - $2.32 Million	176,683 New	176,683 $2.18 Million

Others Institutions Holding TEVA

# of Institutions

603

Shares Held

567M

Call Options Held

25.2M

Put Options Held

5.08M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.8B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Teva Pharmaceutical Industries LTD Transaction History